Get started
Sunshine Biopharma Inc.Sunshine Biopharma Inc.Sunshine Biopharma Inc.

Sunshine Biopharma Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

SBFM chart


Full chart

SBFM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.54 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−51.76 USD
Net income (FY)
‪−5.13 M‬ USD
Revenue (FY)
‪34.87 M‬ USD
Shares float
‪3.23 M‬
Beta (1Y)
1.48

Employees


Employees (FY)
52
Change (1Y)
+8 +18.18%
Revenue / Employee (1Y)
‪670.66 K‬ USD
Net income / Employee (1Y)
‪−98.73 K‬ USD

About Sunshine Biopharma Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Steve N. Slilaty
Website
sunshinebiopharma.com
Headquarters
Fort Lauderdale
Founded
2006
FIGI
BBG000RVLVB7
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SBFM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SBFM.

Frequently Asked Questions


The current price of SBFM is 1.25 USD — it has increased by 2.46% in the past 24 hours. Watch Sunshine Biopharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sunshine Biopharma Inc. stocks are traded under the ticker SBFM.
SBFM stock has fallen by −15.54% compared to the previous week, the month change is a −39.61% fall, over the last year Sunshine Biopharma Inc. has showed a −98.25% decrease.
SBFM reached its all-time high on Aug 2, 2011 with the price of 58,000,000.00 USD, and its all-time low was 1.25 USD and was reached on Apr 7, 2025. View more price dynamics on SBFM chart.
See other stocks reaching their highest and lowest prices.
SBFM stock is 8.38% volatile and has beta coefficient of 1.48. Track Sunshine Biopharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Sunshine Biopharma Inc. there?
Today Sunshine Biopharma Inc. has the market capitalization of ‪4.54 M‬, it has decreased by −13.51% over the last week.
Yes, you can track Sunshine Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
Sunshine Biopharma Inc. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
SBFM net income for the last quarter is ‪−2.16 M‬ USD, while the quarter before that showed ‪−1.20 M‬ USD of net income which accounts for −80.18% change. Track more Sunshine Biopharma Inc. financial stats to get the full picture.
No, SBFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 52 employees. See our rating of the largest employees — is Sunshine Biopharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sunshine Biopharma Inc. EBITDA is ‪−5.54 M‬ USD, and current EBITDA margin is −16.02%. See more stats in Sunshine Biopharma Inc. financial statements.
Like other stocks, SBFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sunshine Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sunshine Biopharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sunshine Biopharma Inc. stock shows the sell signal. See more of Sunshine Biopharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.